The store will not work correctly when cookies are disabled.
3,11-Dihydro-3-oxopyrano[3,2-a]carbazole-2-carboxylic acid
ID: ALA2414995
PubChem CID: 71770035
Max Phase: Preclinical
Molecular Formula: C16H9NO4
Molecular Weight: 279.25
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)c1cc2c(ccc3c4ccccc4[nH]c23)oc1=O
Standard InChI: InChI=1S/C16H9NO4/c18-15(19)11-7-10-13(21-16(11)20)6-5-9-8-3-1-2-4-12(8)17-14(9)10/h1-7,17H,(H,18,19)
Standard InChI Key: IVSBKPZOUQONEV-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
16.7020 -15.4112 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7903 -14.0939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2194 -14.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1689 -13.3801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9446 -15.1077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0000 -14.2939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3239 -13.8409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5920 -14.2006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5404 -15.0177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2173 -15.4671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0296 -14.7527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4561 -15.4380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2644 -15.4114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6444 -14.6937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4116 -14.0396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2123 -14.0134 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9887 -13.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4609 -14.6614 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.6973 -16.1044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3136 -16.8259 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5140 -16.0760 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 6 1 0
5 1 1 0
1 3 1 0
2 3 2 0
3 11 1 0
17 4 2 0
4 2 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
15 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 16 1 0
15 16 1 0
17 15 1 0
14 18 2 0
13 19 1 0
19 20 1 0
19 21 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 279.25 | Molecular Weight (Monoisotopic): 279.0532 | AlogP: 3.13 | #Rotatable Bonds: 1 |
Polar Surface Area: 83.30 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.46 | CX Basic pKa: ┄ | CX LogP: 2.49 | CX LogD: -0.90 |
Aromatic Rings: 4 | Heavy Atoms: 21 | QED Weighted: 0.52 | Np Likeness Score: 0.18 |
References
1. Francisco CS, Rodrigues LR, Cerqueira NM, Oliveira-Campos AM, Rodrigues LM, Esteves AP.. (2013) Synthesis of novel psoralen analogues and their in vitro antitumor activity., 21 (17): [PMID:23886808] [10.1016/j.bmc.2013.06.049] |